223 related articles for article (PubMed ID: 23956301)
1. Human papillomavirus 16-encoded E7 protein inhibits IFN-γ-mediated MHC class I antigen presentation and CTL-induced lysis by blocking IRF-1 expression in mouse keratinocytes.
Zhou F; Chen J; Zhao KN
J Gen Virol; 2013 Nov; 94(Pt 11):2504-2514. PubMed ID: 23956301
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus 16 E7 protein inhibits interferon-γ-mediated enhancement of keratinocyte antigen processing and T-cell lysis.
Zhou F; Leggatt GR; Frazer IH
FEBS J; 2011 Apr; 278(6):955-63. PubMed ID: 21232015
[TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma enhances cytotoxic T lymphocyte recognition of endogenous peptide in keratinocytes without lowering the requirement for surface peptide.
Leggatt GR; Dunn LA; De Kluyver RL; Stewart T; Frazer IH
Immunol Cell Biol; 2002 Oct; 80(5):415-24. PubMed ID: 12225377
[TBL] [Abstract][Full Text] [Related]
4. RNA interference of human papillomavirus type 16 E7 increases HLA class I antigen expression in HaCaT-E7 cells.
Deng XM; Li W; Zhang X; Wang CX; Dong ZG; Zhang X; Zheng GX; Zhang XH; Zheng N; Wang LL; Du LT; Wang S
Int J Gynecol Cancer; 2011 Jan; 21(1):28-34. PubMed ID: 21330828
[TBL] [Abstract][Full Text] [Related]
5. Development of a Spontaneous HPV16 E6/E7-Expressing Head and Neck Squamous Cell Carcinoma in HLA-A2 Transgenic Mice.
Peng S; Xing D; Ferrall L; Tsai YC; Roden RBS; Hung CF; Wu TC
mBio; 2022 Feb; 13(1):e0325221. PubMed ID: 35089069
[TBL] [Abstract][Full Text] [Related]
6. Identification of key amino acid residues that determine the ability of high risk HPV16-E7 to dysregulate major histocompatibility complex class I expression.
Heller C; Weisser T; Mueller-Schickert A; Rufer E; Hoh A; Leonhardt RM; Knittler MR
J Biol Chem; 2011 Apr; 286(13):10983-97. PubMed ID: 21321113
[TBL] [Abstract][Full Text] [Related]
7. Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy.
Mercier-Letondal P; Marton C; Deschamps M; Ferrand C; Vauchy C; Chenut C; Baguet A; Adotévi O; Borg C; Galaine J; Godet Y
Hum Gene Ther; 2018 Oct; 29(10):1202-1212. PubMed ID: 30136612
[TBL] [Abstract][Full Text] [Related]
8. Recruitment of Antigen Presenting Cells to Skin Draining Lymph Node From HPV16E7-Expressing Skin Requires E7-Rb Interaction.
Kuo P; Teoh SM; Tuong ZK; Leggatt GR; Mattarollo SR; Frazer IH
Front Immunol; 2018; 9():2896. PubMed ID: 30619266
[TBL] [Abstract][Full Text] [Related]
9. Paucity of functional CTL epitopes in the E7 oncoprotein of cervical cancer associated human papillomavirus type 16.
Khammanivong V; Liu XS; Liu WJ; Rodda SJ; Leggatt GR; Tindle RW; Frazer IH; Fernando GJ
Immunol Cell Biol; 2003 Feb; 81(1):1-7. PubMed ID: 12534940
[TBL] [Abstract][Full Text] [Related]
10. Epithelium Expressing the E7 Oncoprotein of HPV16 Attracts Immune-Modulatory Dendritic Cells to the Skin and Suppresses Their Antigen-Processing Capacity.
Chandra J; Miao Y; Romoff N; Frazer IH
PLoS One; 2016; 11(3):e0152886. PubMed ID: 27031095
[TBL] [Abstract][Full Text] [Related]
11. Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6.
Evans M; Borysiewicz LK; Evans AS; Rowe M; Jones M; Gileadi U; Cerundolo V; Man S
J Immunol; 2001 Nov; 167(9):5420-8. PubMed ID: 11673561
[TBL] [Abstract][Full Text] [Related]
12. High Levels of EBV-Encoded RNA 1 (EBER1) Trigger Interferon and Inflammation-Related Genes in Keratinocytes Expressing HPV16 E6/E7.
Aromseree S; Middeldorp JM; Pientong C; van Eijndhoven M; Ramayanti O; Lougheed SM; Pegtel DM; Steenbergen RD; Ekalaksananan T
PLoS One; 2017; 12(1):e0169290. PubMed ID: 28056059
[TBL] [Abstract][Full Text] [Related]
13. Fungal mannosylation enhances human papillomavirus 16 E7 therapeutic immunity against TC-1 tumors.
Wang Z; Wei C; Zhang Y; Wang W; Zhou Z; Xiao G
Oncol Rep; 2018 Jan; 39(1):425-432. PubMed ID: 29115562
[TBL] [Abstract][Full Text] [Related]
14. HPV16 E7-Driven Epithelial Hyperplasia Promotes Impaired Antigen Presentation and Regulatory T-Cell Development.
Bashaw AA; Teoh SM; Tuong ZK; Leggatt GR; Frazer IH; Chandra J
J Invest Dermatol; 2019 Dec; 139(12):2467-2476.e3. PubMed ID: 31207230
[TBL] [Abstract][Full Text] [Related]
15. Limitations of HLA-transgenic mice in presentation of HLA-restricted cytotoxic T-cell epitopes from endogenously processed human papillomavirus type 16 E7 protein.
Street MD; Doan T; Herd KA; Tindle RW
Immunology; 2002 Aug; 106(4):526-36. PubMed ID: 12153516
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation.
Zhou F
Int Rev Immunol; 2009; 28(3-4):239-60. PubMed ID: 19811323
[TBL] [Abstract][Full Text] [Related]
17. Increased Response of Human T-Lymphocytes by Dendritic Cells Pulsed with HPV16E7 and Pleurotus sajor-caju-β-glucan (PBG).
Roopngam PE
Iran J Immunol; 2018 Dec; 15(4):246-255. PubMed ID: 30593739
[TBL] [Abstract][Full Text] [Related]
18. Recognition of keratinocytes by cytotoxic T cells specific for conventional HLA class-I alloantigen.
Symington FW; Santos EB
J Invest Dermatol; 1990 Aug; 95(2):224-8. PubMed ID: 2116484
[TBL] [Abstract][Full Text] [Related]
19. Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopes.
van der Burg SH; Ressing ME; Kwappenberg KM; de Jong A; Straathof K; de Jong J; Geluk A; van Meijgaarden KE; Franken KL; Ottenhoff TH; Fleuren GJ; Kenter G; Melief CJ; Offringa R
Int J Cancer; 2001 Mar; 91(5):612-8. PubMed ID: 11267969
[TBL] [Abstract][Full Text] [Related]
20. Immunization of mice by the co-administration of codon-optimized HPV16 E7 and lL12 genes against HPV16-associated cervical cancer.
Ajorloo M; Alamdary A; Soleimanjahi H; El Boulani A; Khanizadeh S; Nikoo HR
Microb Pathog; 2019 Jul; 132():20-25. PubMed ID: 31004722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
